Global Vagus Nerve Stimulator market

Vagus Nerve Stimulator Market was valued at USD 552.74 Mn in 2024, and total global Vagus Nerve Stimulator Market revenue is expected to grow at a CAGR of 11.3% from 2025 to 2032, reaching nearly USD 1301.61 Mn, led by North America.

Vagus Nerve Stimulator Market Overview

Vagus Nerve Stimulator Market is global industry focused on development and distribution of implantable and non-invasive devices are used to stimulate vagus nerve for therapeutic purpose, are used to treat neurological and psychiatric disorders including epilepsy, depression and migraine. The therapy enhances patient outcomes by modulating brain activity and reducing frequency and severity of symptoms. Increasing prevalence of treatment resistant neurological conditions and growing demand for alternative, non-pharmaceutical solution is a major driver. Technological innovations such as closed loop VNS systems, wearable devices and AI-integrated neurostimulators are expanding product offerings for supply chain. Market growth is also fueled by rising clinical trials and supportive regulatory approvals. North America dominates Vagus Nerve Stimulator Market by its strong healthcare infrastructure, early technology adoption and presence of key players like Medtronic plc, LivaNova plc and electroCore Inc. Asia Pacific is fastest growing region, driven by rising healthcare awareness, aging population and increased investment in neuroscience research and medical devices. Key players like Medtronic plc, electroCore Inc. and LivaNova plc are actively investing in R&D, clinical trials and strategic partnerships to expand indications and improve device efficacy.

Report covers the Vagus Nerve Stimulator Market dynamic, structure by analysing the market segments and projecting Vagus Nerve Stimulator Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies and regional presence in Vagus Nerve Stimulator Market.To know about the Research Methodology  :- Request Free Sample Report

Vagus Nerve Stimulator Market Dynamics

Innovative Non-invasive Vagus Nerve Stimulation Devices to Drive the Market Growth

Vagus nerve stimulation is a technique of electrically stimulating the vagus nerve, which controls specific functions and areas of the brain. Traditional and conventional vagus nerve stimulation devices are implanted in the patient’s body and leads are placed on the vagus nerve, which provide electrical stimulation whenever required. Technological advances and growing demand for innovative devices has led to the introduction of small-sized implantable VNS devices in the market. These small-sized implantable devices offer various clinical benefits to patients and healthcare providers. Introduction of innovative devices is anticipated to drive the growth of the global market during the forecast period.

Constant focus by market players to innovate and introduce new products has led to emergence of non-invasive vagus nerve stimulation (nVNS) devices in the market. These devices are also known as transcutaneous vagus nerve stimulation devices (tVNS). For example, gammaCore (nVNS), a non-invasive vagus nerve stimulation device from electroCore Inc., received US FDA approval in late 2019. This device offers clinical benefits including avoiding surgical procedures to implant and replacing the implanted devices, thereby eliminating the side effects associated with implantable devices. Other market players including tVNS Technologies GmbH, Parasym Ltd., among others have also received US FDA and CE Mark approvals for their non-invasive VNS devices. This is projected to drive the adoption of these devices and drive the growth of the vagus nerve stimulation market trends during the forecast period.

High Cost of Surgical Implantation and Lower Treatment Rates in Emerging Countries to Restrain the Adoption of VNS Devices

Increasing incidence of epilepsy, depression, and other chronic conditions globally, and higher prevalence of these conditions in emerging countries, there are certain factors that are limiting the adoption of VNS devices. One of the major factors restraining the growth of the market is lower treatment rates in emerging countries for neurological disorders. This is presenting a limited number of patients undergoing treatment, and out of those, a large proportion still prefer regular medication for treatment of these conditions. This further limits the number of patients preferring VNS treatment. Added to this is the high cost of implantable VNS devices, along with high cost of the surgery, and lack of approved non-invasive VNS devices, are some of the major factors restraining the market growth.

Vagus Nerve Stimulator Market Segmentation

Based on the product, the vagus nerve stimulation market is segmented into implantable and external VNS devices. The implantable VNS device segment dominated the market with an increase in the number of patients suffering from different types of headaches, depression, and epilepsy. The implanted VNS devices are specialized to act directly on the pain spot and they alter nerve activity by sending electrical stimulation to a particular nerve, thereby making it a more effective way of treating the disease. An implantable VNS device is helpful for those who have not responded to anti-seizure drugs and intensive depression treatments, such as antidepressant medications, psychotherapy, and electroconvulsive therapy (ECT). Furthermore, the introduction of new and innovative products by key market players is fueling the demand and adoption of VNS devices in the global market. For instance, in August 2021, the FDA approved the MicroTransponder Vivistim Paired VNS System, a drug rehabilitation system intended to treat moderate to severe upper extremity motor deficits due to chronic ischemic stroke. The external VNS device segment is expected to expand at the highest growth rate from 2025 to 2032. This is attributed to the increasing number of patients with chronic disorders, the rising demand for non-invasive therapy, and the cost-effectiveness of the device. The introduction of new devices by market players and the shift of patient preference towards non-invasive devices are factors projected to fuel the demand for these devices and drive market growth during the forecast period.

Vagus Nerve Stimulator Market Regional Anlaysis

North America dominated the vagus nerve stimulation market in 2024, owing to the increase in government funding and initiatives for raising awareness about epilepsy and difficult-to-treat depression in the region. Also, rapid technological advancements, the presence of key manufacturers in the region, an increase in R&D investments, and a rise in the number of government funding and initiatives are among the key factors expected to create significant growth opportunities in the market. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is expected to grow at 5.5% every year from 2018 to 2027 and is estimated to reach USD 6 trillion by 2027. In addition, high disposable income in developed economies and the availability of skilled professionals are some of the factors responsible for the large share of the North American region in the market.

Vagus Nerve Stimulator Market Competitive Landscape

Medtronic plc, ElectroCore and MicroTransponder leads the Vagus Nerve Stimulator market, leveraging cutting edge technology, clinical research and strategic expansion to drive global growth. These firms dominate through innovation in implantable and non-invasive neuromodulation therapies, targeting neurological, psychiatric and chronic pain disorders. Medtronic plc, is global leader in medical technology, dominates the VNS space with FDA approved implantable solutions used primarily for epilepsy and treatment resistant depression. In 2024, Medtronic nearly 8% invested in R&D, its VNS Therapy system is widely adopted due to clinical efficacy and broad insurance coverage. The company maintains strong market positions in North America and Europe through a vast hospital network and ongoing product development in closed loop VNS systems. ElectroCore, is a pioneer in non-invasive VNS and markets the gammaCore device, approved for migraines, cluster headaches, and PTSD related symptoms. The company capitalizes on telemedicine and military contracts to expand access. In 2024, it reported double-digit revenue growth and partnerships with U.S. government health agencies. Its compact, handheld device tests it from implant-based solutions, supporting patient-friendly, on-demand nerve stimulation. Micro Transponder, is known for Vivistim Paired VNS System, MicroTransponder focuses on post-stroke rehabilitation through neuroplasticity-based therapy. Its solution was FDA approved in 2021 and has gained traction in neurological rehab centers across the U.S. and Europe. The company emphasizes clinical efficacy and mobility restoration and continues to secure funding for expanding VNS applications in cognitive recovery and tinnitus treatment.

Vagus Nerve Stimulator Market Trends

Vagus Nerve Stimulator Market Key Developments

• June 5th 2025, Liova Nova plc, released a study showing a 77% reduction in tonic-clonic seizures for drug-resistant epilepsy patients.
• In March 2025, MicroTransponder, Inc. secured USD 65M Series F funding to scale operations and advance R&D for its FDA-approved Vivistim Paired VNS system aimed at stroke rehabilitation.
• June 6th 2024, LivaNova plc, announced positive outcomes from the Recover depression trial for VNS therapy in unipolar depression patients.
• In 2024, Boston Scientific Corp., continued its acquisition strategy with major deals in 2023 and 2024, including Baylis Medical and Axonics to diversify its neuromodulation segment alongside VNS exploration.
• June 3rd 2023, electroCore, Inc., gammaCore non-invasive VNS device was added to the NHS Supply Chain list for migraine and cluster headache treatment.

Vagus Nerve Stimulator Market Scope : Inquire before buying

Vagus Nerve Stimulator Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Vagus Nerve Stimulator Market Key Players

North America

1. Medtronic plc (U.S)
2. ElectroCore, Inc. (U.S)
3. Micro Transponder, Inc. (U.S)
4. Boston Scientific Corporation (U.S)
5. NeuroPace, Inc. (U.S)
6. Soterix Medical Inc. (U.S)
7. Cyberonics Inc. (U.S)
8. Synapse Biomedical Inc. (U.S)
9. NeuroSigma, Inc. (U.S)
10. NeuroMetrix Inc. (U.S)

Europe

11. LivaNova plc (UK)
12. Cerbomed GmbH (Germany)
13. J. Wagner GmbH (Germany)
14. Biocontrol Medical Ltd. (Israel)
15. NEMOS (Germany)
16. Synergia Medical SA (Belgium)
17. Soterix Europe (Germany)
18. ReShape Lifesciences (UK)
19. Inomed Medizintechnik GmbH (Germany)
20. MindMaze SA (Switzerland)

Asia Pacific

21. PINS Medical Co. Ltd. (China)
22. Nervana LLC (Thailand)
23. Japan Lifeline Co., Ltd. (Japan)
24. Medico Electrodes Intl Ltd. (India)
25. Shanghai MicroPort Co., Ltd. (China)

Middle East & Africa

26. Biocontrol Medical Ltd. (Israel)
27. BrainQ Technologies Ltd. (Israel)

South America

28. LivaNova plc (Argentina)

FAQs

1] Which region has the largest share in Global Vagus Nerve Stimulator Market?
Ans: North America region holds the highest share in 2024.

2. What is the growth rate of Global Vagus Nerve Stimulator Market?
Ans: The Global Vagus Nerve Stimulator Market is growing at a CAGR of 11.3% during forecasting period 2025-2032.

3. What is scope of the Global Vagus Nerve Stimulator market report?
Ans: Global Vagus Nerve Stimulator Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Vagus Nerve Stimulator market?
Ans: The important key players in the Global Vagus Nerve Stimulator Market are Entero Medics Inc. (US), Electro Core Medical LLC (US), Beijing Medical Equipment, Boston Scientific Corporation (US), Cyberonics, Inc. (US), NeuroMetrix, Inc. (US), ImThera Medical (US).

5. What is the study period of this market?
Ans: The Global Vagus Nerve Stimulator Market is studied from 2025 to 2032.